Medicine and Dentistry
Vincristine
100%
Neoplasm
54%
Binding Affinity
45%
Drug Retention
45%
Xenograft
36%
Vinca Alkaloid
36%
Rhabdomyosarcoma
36%
Tubulin
27%
Protein
18%
Tritium
18%
Drug Binding
18%
Membrane
18%
High-Performance Liquid Chromatography
9%
Monoclonal Antibody
9%
Nitrocellulose
9%
Iodine 125
9%
Drug Resistance
9%
Vinblastine
9%
Tumor Progression
9%
Binding Site
9%
Drug Sensitivity
9%
Filtration
9%
Fitting Curve
9%
Species
9%
Tissues
9%
Chemistry
Vincristine
100%
Kd
90%
Tubulin
54%
Vinca Alkaloid
36%
Resistance
36%
Concentration
27%
Electron Affinity
27%
Protein
18%
Intrinsic Resistance
18%
High Performance Liquid Chromatography
18%
Molecular Mass
9%
Binding Site
9%
Size Exclusion Chromatography
9%
Nitrocellulose
9%
Retention Time
9%
Monoclonals
9%
Time
9%
Gel
9%
Crudity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Vincristine
100%
Neoplasm
54%
Vinca Alkaloid
36%
Rhabdomyosarcoma
36%
Tubulin
27%
Protein
18%
Drug Concentration
18%
Tritium
18%
Pyroxylin
9%
Iodine-125
9%
Binding Site
9%
Monoclonal Antibody
9%
Vinblastine
9%
Tumor Growth
9%
Drug Resistance
9%
Elimination
9%
Biochemistry, Genetics and Molecular Biology
Binding Affinity
45%
Drug Retention
45%
Alkaloid
36%
Vinca
36%
Membrane
18%
Drug Concentration
18%
Drug Binding
18%
Protein
18%
Binding Site
9%
Monoclonal Antibody
9%
Molecular Weight
9%
Dissociation Constant
9%
Gel Filtration
9%
Retention Time
9%
Drug Resistance
9%
Nitrocellulose
9%
Growth
9%
Drug Sensitivity
9%
Time
9%
Species
9%
Veterinary Science and Veterinary Medicine
Rhabdomyosarcoma
36%
Binding Site
9%